Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A case report highlights the successful use of conversion surgery following pembrolizumab treatment in a patient with initially unresectable MSI-H small bowel adenocarcinoma. This analysis may provide insights into potential treatment pathways for similar cases.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.